Xoma reported $-4178000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US USD 3.95B 3.03B
Agenus AGEN:US USD -54222000 7.79M
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
Biomarin Pharmaceutical BMRN:US USD -6652000 34.32M
Bluebird Bio BLUE:US USD -76520000 23.62M
Chimerix CMRX:US USD 241.36M 264.83M
Eli Lilly And LLY:US USD 1.45B 499.2M
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
Life Technologies LIFE:US USD -13244000 824K
Macrogenics MGNX:US USD -24813000 16.49M
Novartis NOVN:VX USD 1.57B 121M
Novartis NVS:US USD 1.57B 121M
Pfizer PFE:US USD 8.61B 1.3B
Regeneron Pharmaceuticals REGN:US USD 1.32B 463.6M
Teva Pharmaceutical Industries TEVA:US USD 55M 288M
Xoma XOMA:US USD -4178000 492K
YTE INCY:US USD 112.78M 48.66M